http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-066834-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D223-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 |
filingDate | 2008-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2009-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AR-066834-A1 |
titleOfInvention | ESPIROBENZOAZEPANOS AS VASOPRESINE ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESS AND USES FOR THE TREATMENT OF CARDIAC, RENAL AND NERVOUS SYSTEMS. |
abstract | Claim 1: A compound having the general structure shown in formula (1), or a form thereof, wherein, Ring A is selected from the group consisting of Ring R1a, Ring R1b, Ring R1c, Ring R1d , Ring R1e, Ring R1f, Ring R1g, Ring R1h, Ring R1i, Ring R2a, Ring R2b, Ring R2c, Ring R2d, Ring R2e, Ring R2f, Ring R2g, Ring R2h, and Ring R2i, of formulas (2), U is phenyl-carbonyl-amino, biphenyl-carbonyl-amino, heterocyclyl or heteroaryl, where heterocyclyl and heteroaryl are optionally substituted, individually, with C1-4 acid , and where each phenyl is optionally substituted with one, two or three substituents independently selected from C 1-4 alkyl, C 1-4 alkoxy, halogen, hydroxy, carboxy, amino, C 1-4 alkyl or C 1-4 dialkyl; You see CH or N; W is hydrogen or C1-3 alkoxy; R 1 is amino, C 1-4 alkyl-amino, C 1-4 dialkyl, hydroxy-amino, C 1-4 alkyl-carbonyl amino, C 1-4 alkyl-C 1-4 alkyl-carbonyl-amino, dialkyl C1-4-amino-C1-4 alkyl-carbonyl-amino, amino-sulfonyl-amino, C1-4-imino alkyl, C1-4-imino alkoxy, hydroxy-imino, amino-imino, C1-4-amino-imino alkyl , C1-4-alkylimino imino, C1-4-imino amino-alkoxy, C1-4-alkyl-C1-4-imino alkoxy, C1-4-alkyl-C1-4-imino alkoxy, heteroaryl, heteroaryl -amino-imino or heteroaryl-carbonyl-amino-imino, where each heteroaryl is optionally substituted with C1-4alkyl; and, R2 is oxo, amino, C 1-4 alkyl, amino C 1-4 alkyl, hydroxy amino, C 1-4 alkyl, C 1-4 alkyl-C 1-4 alkyl, C 1-4 dialkyl aminoC 1-4 alkyl, aminoC 1-4 alkyl-amino, C 1-4 alkyl-C 1-4 alkyl-amino, C 1-4 alkyl-amino-sulfonyl amino, amino-sulfonyl-amino, amino-sulfonyl-amino-carbonyl, C1-4-alkyl-sulfonyl-amino-carbonyl, C1-4-dialkyl-sulfonyl-amino-carbonyl, C1-4-alkoxy-methylene, carboxy-methylene, amino-carbonyl -methylene, C1-4 alkyl-amino-carbonyl-methylene, dialkyl C1-4-amino-carbonyl-methylene, hydroxy-C1-4-alkyl-carbonyl-methylene, amino-C1-4 alkyl-amino-carbonyl-methylene , C 1-4 alkyl-C 1-4 alkyl-amino-carbonyl-methylene, C 1-4 dialkyl-C 1-4 alkyl-amino-carbonyl-methylene, heterocyclyl-C 1-4 alkyl-amino-carbonyl-methylene, C1-4-imino alkyl, C1-4-imino alkoxy, hydroxy-imino, C1-4-imino carboxy-alkoxy, amino-imino, C1-4-amino-imino alkyl, C1-4-alkyl-imino dialkyl, aryl -oxy-imino, heterocyclyl or heteroaryl, don of heterocyclyl and heteroaryl are optionally substituted, individually, with C1-4 alkyl. |
priorityDate | 2007-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.